166 related articles for article (PubMed ID: 16552811)
1. Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients.
Kobayashi M; Sakamoto J; Namikawa T; Okamoto K; Okabayashi T; Ichikawa K; Araki K
World J Gastroenterol; 2006 Mar; 12(9):1412-5. PubMed ID: 16552811
[TBL] [Abstract][Full Text] [Related]
2. [A case of advanced gastric cancer treated with weekly paclitaxel with measurement of paclitaxel concentrations in blood and ascites].
Kojima T; Matsui T; Uemura T; Fujimitsu Y; Kato J; Kojima H
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1529-31. PubMed ID: 14584291
[TBL] [Abstract][Full Text] [Related]
3. Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer.
Imamoto H; Oba K; Sakamoto J; Iishi H; Narahara H; Yumiba T; Morimoto T; Nakamura M; Oriuchi N; Kakutani C; Morita S; Shiozaki H
Gastric Cancer; 2011 Mar; 14(1):81-90. PubMed ID: 21327925
[TBL] [Abstract][Full Text] [Related]
4. [A case of advanced gastric cancer with malignant ascites responding to weekly paclitaxel therapy].
Toyokawa T; Sawada T; Muguruma K; Kim T; Kimura K; Inoue T; Yamashita Y; Yashiro M; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1637-40. PubMed ID: 17108715
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of docetaxel in gastric cancer patients with malignant ascites.
Tamegai H; Kaiga T; Kochi M; Fujii M; Kanamori N; Mihara Y; Funada T; Shimizu H; Jinno D; Takayama T
Cancer Chemother Pharmacol; 2013 Mar; 71(3):727-31. PubMed ID: 23314679
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic study of weekly administration dose of paclitaxel in patients with advanced or recurrent gastric cancer in Japan.
Kobayashi M; Oba K; Sakamoto J; Kondo K; Nagata N; Okabayashi T; Namikawa T; Hanazaki K
Gastric Cancer; 2007; 10(1):52-7. PubMed ID: 17334719
[TBL] [Abstract][Full Text] [Related]
7. A phase II clinical trial to evaluate the effect of paclitaxel in patients with ascites caused by advanced or recurrent gastric carcinoma: a new concept of clinical benefit response for non-measurable type of gastric cancer.
Sakamoto J; Morita S; Yumiba T; Narahara H; Kinoshita K; Nakane Y; Imamoto H; Shiozaki H;
Jpn J Clin Oncol; 2003 May; 33(5):238-40. PubMed ID: 12865468
[TBL] [Abstract][Full Text] [Related]
8. [Recurrent ovarian cancer with cancer peritonitis treated with weekly paclitaxel infusion--a clinicopharmacological study].
Urabe S; Fujiwara H; Egawa M; Fujitou N; Sakashita T; Date K; Mizunoe T; Ueda K; Urabe T
Gan To Kagaku Ryoho; 2004 Mar; 31(3):449-51. PubMed ID: 15045960
[TBL] [Abstract][Full Text] [Related]
9. A case of scirrhous gastric cancer with peritonitis carcinomatosa controlled by TS-1 + paclitaxel for 36 mo after diagnosis.
Koizumi Y; Obata H; Hara A; Nishimura T; Sakamoto K; Fujiyama Y
World J Gastroenterol; 2007 Jan; 13(3):470-3. PubMed ID: 17230622
[TBL] [Abstract][Full Text] [Related]
10. [A case of recurrent gastric cancer with malignant ascites responding dramatically to chemotherapy with paclitaxel infused systemically and intraperitoneally].
Morifuji M; Murakami Y; Yokoyama Y; Sasaki M; Hayashidani Y; Toge K; Sueda T
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2027-30. PubMed ID: 15570933
[TBL] [Abstract][Full Text] [Related]
11. [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Nakamura T; Shimada K; Okubo Y; Tanaka S; Tanabe S; Yoshida M; Doi K; Uchinami M; Horiuchi T; Tanaka K
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1423-6. PubMed ID: 15446570
[TBL] [Abstract][Full Text] [Related]
12. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
[TBL] [Abstract][Full Text] [Related]
13. Weekly paclitaxel in combination with doxifluridine for peritoneally disseminated gastric cancer with malignant ascites.
Takeyoshi I; Makita F; Iwazaki S; Ishikawa H; Kakinuma S; Sato Y; Ohya T; Nakagami K; Tomizawa N; Izumi M; Kobayashi I; Tanahashi Y; Kobayashi J; Kamoshita N; Kawate S; Sunose Y; Sakamoto I; Yoshinari D; Yamada T; Okabe T
Anticancer Res; 2011 Dec; 31(12):4625-30. PubMed ID: 22199340
[TBL] [Abstract][Full Text] [Related]
14. Weekly intravenous and intraperitoneal paclitaxel combined with S-1 for malignant ascites due to advanced gastric cancer.
Kitayama J; Ishigami H; Kaisaki S; Hidemura A; Kato M; Otani K; Kamei T; Soma D; Miyato H; Yamashita H; Nagawa H
Oncology; 2010; 78(1):40-6. PubMed ID: 20197706
[TBL] [Abstract][Full Text] [Related]
15. [Two cases of advanced gastric cancer with peritonitis carcinomatosa that showed disappearance of ascites and obtained a good quality of life by using DIF and paclitaxel].
Okumura K; Tani S; Shiogai Y; Kodama M; Mekata E; Tan T
Gan To Kagaku Ryoho; 2012 Apr; 39(4):667-70. PubMed ID: 22504699
[TBL] [Abstract][Full Text] [Related]
16. [An effective weekly paclitaxel administration for gastric cancer with malignant ascites--a case report].
Koide A; Maruyama M; Hasegawa K; Miyawaki Y; Tamura N; Ohbu M; Maruyama S; Takashima I; Ebuchi M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1752-4. PubMed ID: 16315930
[TBL] [Abstract][Full Text] [Related]
17. [Effective weekly paclitaxel administration for gastric cancer with malignant ascites--a case report].
Ishida T; Shimokawa H; Kawaguchi K; Nose N; Ikegami T; Itoh H; Kido A; Sasaki Y; Ezaki T
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1643-6. PubMed ID: 12355953
[TBL] [Abstract][Full Text] [Related]
18. [Measurement of docetaxel concentration in blood and ascites after drip infusion into each vessel and intraperitoneal cavity of gastric cancer].
Naitoh H; Kawaguch A; Yamamoto H; Mekata E; Tan T; Morii H; Chiba M
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2031-4. PubMed ID: 15570934
[TBL] [Abstract][Full Text] [Related]
19. Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin.
Ohbatake Y; Fushida S; Tsukada T; Kinoshita J; Oyama K; Hayashi H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Yashiro M; Hirakawa K; Ohta T
Clin Exp Med; 2016 Nov; 16(4):585-592. PubMed ID: 26359244
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of weekly administration of paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
Hikino H; Yamada T; Hata T; Nakamura K; Sugimoto S; Kanazawa A; Tokuka A; Ozaki N
Gan To Kagaku Ryoho; 2004 May; 31(5):759-61. PubMed ID: 15170988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
